This monograph is based on the workshop "Linking Environmental Agents and Autoimmune Diseases" held at the National Institute of Environmental Health Sciences held 1-3 September 1998. The workshop brought together immunologists, clinicians, epidemiologists, molecular biologists, and toxicologists to review current knowledge about environmental links to autoimmune disease and to identify data gaps and future research needs. (Environmental agents were defined as xenobiotic chemicals in the environment; viruses and infectious agents were not considered in this particular workshop.)
The impetus for the workshop was the question of whether environmental agents affect the development or progression of autoimmune disease. If so, the ultimate goal is to understand the role of environmental agents and the underlying mechanisms through which these agents act so that the potential risks of exposure to these agents can be assessed and reduced. assessment techniques (as well as biologic markers of exposure or response) needed for large-scale studies.
The National Research Council of the National Academy of Sciences has defined risk assessment as comprising some or all of the following components: hazard identification, dose response, exposure assessment, and risk characterization (4) . Hazard identification is a qualitative assessment that addresses the question, "What types of effects occur as a result of chemical exposure?" In this case, the question would be "Does a chemical have the potential to induce or exacerbate autoimmune disease?" Dose response is a quantitative assessment and broadly interpreted addresses the question, "Under what conditions does a chemical cause these effects in humans?" Exposure assessment is an analysis of the level of exposure in the environment and the numbers and types of individuals that are likely to be exposed. Finally, all of this information is integrated to develop a risk characterization. It is clear from the foregoing that the state of the science with respect to environmental agents and autoimmune disease is in the early stages of hazard identification.
The peer-reviewed papers in this monograph are divided into six sections on the basis ofworkshop sessions: the first section includes an introduction to the immunology of autoimmunity and autoimmune diseases and articles on the evidence for the role of environmental agents in the initiation or progression of autoimmune conditions, available screening tests, and considerations for risk assessment; the second section covers several different issues regarding susceptibility and susceptible populations; the third section focuses on clinical, experimental animal models, and epidemiologic studies of systemic autoimmune diseases (scleroderma and systemic lupus erythematosus); the fourth section includes some examples of what are considered more organ-specific diseases (e.g., thyroiditis); the fifth section contains articles about specific exposures and mechanisms (e.g., hexachlorobenzene, silica); and the final section consists of the consensus of research needs and priorities developed by workshop participants. This monograph is intended to provide a resource for developing a research strategy to address potential links between environmental agents and autoimmune disease, including the important issue of the interaction between genetic, hormonal, and environmental factors involved in the etiology and progression of autoimmune diseases.
